Alnylam Pharmaceuticals

We are grateful to partner with Bay Cove Human Services and CASPAR Shelters for their annual Give Warmth Give Hope campaign. Our employees continue to show compassion and commitment by supporting our neighbors experiencing homelessness, especially during the coldest months of the year. We are proud to stand alongside our community partners in helping provide essential winter items and hot meals to those who need them most.

We’re proud to share that Sculpta Bio, has won our 2025 BioVenture Challenge pitch competition, and been awarded the Alnylam Science and Entrepreneurship Award. This $100,000 grand prize will help them advance their innovative technology, which has the potential to help improve the lives of patients impacted by diseases of the brain. Congratulations to Dr. Neal Amin and the Sculpta Bio team on this well-deserved recognition. Thank you to all the teams that participated this year, and to Nucleate for their continued partnership and all they do to fuel the next generation of biotech leaders. #Innovation, #BioVentureChallenge, #ChallengeAccepted, #Biotechnology

In Boston, life expectancy can differ by up to 23 years between neighborhoods located just miles apart. To help address this, we’re investing $2 million through our Alnylam Challengers program to support frontline Care Navigators who help the hardest to reach patients in underserved communities access vital social and medical services. Together with leading institutions Boston Children's Hospital, Boston Medical Center (BMC), and Whittier Street Health Center, we’re working to reduce disparities and improve health outcomes for those who need it most. Learn more about this new program: https://bit.ly/4pgF07k #AlnylamChallengers #CareNavigation #BostonHealth #CorporateResponsibility

For Healthcare Professionals: When it comes to transthyretin amyloidosis with cardiomyopathy (ATTR-CM), progression can be fast and detrimental. If you suspect a patient may have ATTR-CM, a timely diagnosis is essential. Learn how to confirm or rule out ATTR-CM: https://bit.ly/3LJtumq

This #VeteransDay, we honor the courage and commitment of all who have served, especially the veterans within our Alnylam community. Your service inspires us, and your continued contributions make us #AlnylamProud. Thank you.

🔗 https://bit.ly/3DEiiUB Doctors appointments, tests, pharmacy visits, medication routines - the sounds of these things make living with disease noisy. But when disease is silenced, these things become less prevalent and the everyday joys of life can be amplified. We've pioneered #RNAi therapeutics to do just that - #SilenceDisease to #AmplifyLife.

The Alnylam Assist® program offers support services to patients who are prescribed one of our products. Our team of experts are here to help patients access and understand treatment. https://bit.ly/3URXbSy

Women's pain is often blamed on stress, hormones, or branded as "normal," which can lead to delayed diagnosis of serious conditions. That was the case for Donna, whose journey to a diagnosis of acute hepatic #porphyria (AHP) spanned over 10 years. Recognizing and investigating seemingly disparate symptoms such as those experienced by people with AHP can help patients like Donna regain control of their lives. Read more about her symptoms and story: https://bit.ly/3Xs0KBp #raredisease #womenshealth

As we approach #WorldAmyloidosisDay, the voices of those living with ATTR amyloidosis and those who care for them remind us that optimal care should reflect individual needs, beyond the clinical symptoms of disease. At Alnylam, we’re proud to help raise awareness with, and on behalf of, the community.